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Abstract 
Background:  Tourniquets and new hemostatic pressure dressings effectively prevent 
exsanguination from most extremity wounds.  The unmet need is effective control of truncal 
bleeding.  Cessation of hemorrhage soon after injury is essential for survival in cases where 
vascular injury is severe and the coagulopathy of trauma is present. However, few products exist 
that are highly effective for solid organ damage.  Hemostatic agents that can be used in the 
operating room are desirable. 
 
Methods:  In this proof of principle study, animals received a standard liver injury to the left 
central lobe.  Four animals each were assigned to no treatment (negative control), QuickClot®, 
Hemcon® bandage, and keratin gel treatment groups.  All treatments were administered without 
compression and within five minutes of injury.  Hemodynamic variables and other data were 
recorded during surgery, blood samples for CBC were taken during and after surgery, and all 
surviving animals were sacrificed after 72 hours. 
 
Results:  24 hour survival rates were 0%, 50%, 50%, and 100% for the no treatment, QuickClot, 
Hemcon, and keratin gel groups, respectively.  The keratin and QuickClot groups showed a 
significant reduction in shed blood volume compared to the control (p < 0.05).  The keratin gel 
group also demonstrated greater maintenance of mean arterial pressure and the lowest shock 
index (HR/MAP). 
 
Conclusions:  The keratin gel used in this preliminary study produced favorable outcomes and 
warrants additional investigation as a hemostatic agent.  The keratin’s gelatinous consistency, 
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ease of application and efficacy without compression may make it amendable to use in many 
settings. 
 
Keywords:  Keratin, biomaterial, hemostasis, liver trauma, hemorrhage 
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Introduction 
Rapid, voluminous hemorrhage instigates a cascade of events that are almost impossible to 
reverse without immediate and effective intervention.  According to the Centers for Disease 
control, motor vehicle trauma is the leading cause of death for Americans under age 64 with 
more than 40,000 victims per year.1  The number of people who die from motor vehicle-related 
injuries has not changed for the past 10 years.  Historically, more than half of those severely 
injured with concomitant hemorrhage die.  While it has been shown that immediate intervention 
is the best method to limit patient mortality,2 the methods for controlling bleeding in the pre-
hospital setting have not substantively changed for centuries.3  Thus, many new hemostatic 
products have been developed to try to meet this need.  Tourniquets and recent innovations in 
hemostatic pressure dressings have been effective for treatment of surface and extremity wounds, 
but there are few options for head, neck, chest, and abdominal hemorrhage. 
 
On the battlefield, seventy percent of ballistic injuries result in death within the first hour.  This 
is due primarily to the massive blood loss associated with penetrating trauma.  In Vietnam, five 
thousand deaths resulted from bleeding from the extremities.  It was estimated that twenty 
percent of these casualties could have been avoided with better first aid.4  Surprisingly, the 
percent of wounded who survive the first hour has not changed since the US Civil War.  In Iraq 
and Afghanistan, like in all previous wars, extremity wounds are the predominant injury.  Deaths 
due to hemorrhage represents the majority of those killed in action in Iraq.5,6 
 
Many products exist that effectively treat hemorrhage from the extremities (e.g. tourniquets and 
hemostatic pressure dressings) as well as those that work systemically.  Numerous large animal 
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preclinical and human clinical trials have been conducted and published, and many comparative 
investigations of hemostatic agents have been undertaken.7-9  Coagulation adjuvants include 
mineral-based granules (e.g. QuickClot®),10-13 numerous dressings,14-18 clotting factors,19,20 and 
surgical approaches.21,22  Results have been mixed and are dependent on the model used.  The 
zeolite-based QuickClot material has done well in some large animal trials, as has the chitosan-
based bandage, Hemcon.  In one extensive comparative trial, fibrin dressings were clearly 
superior.7  However, each of these hemostats has its challenges and limitations.  QuickClot is 
known to produce localized heating which has been shown to damage tissue, both Hemcon and 
QuickClot are not intended for internal injuries and must be removed from the wound site, and 
fibrin bandages are expensive and not yet approved by the Food and Drug Administration.  None 
of these materials, with the exception of a fibrin foam product that is still in development, can be 
applied without clear access to the site of hemorrhage, a major goal of first responders. 
 
In the present investigation, we have tested a novel biomaterial derived from human hair that has 
demonstrated interesting hemostatic properties.  Hard keratins are the constitutive proteins found 
in the protective structure of vertebrates, most notably in hair fibers.  Numerous methods exist to 
extract keratins from hair fibers and process the soluble proteins into films and gels.23  Numerous 
products utilize hydrolyzed keratins, most notably in personal care applications and drug 
formulations.  In early experiments, we discovered that certain keratin preparations instigated 
excessive red blood cell aggregation when exposed to fresh whole blood.  We have now 
developed a powerful hemostatic keratin gel and tested it in a rabbit liver hemorrhage model. 
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Materials and Methods 
Keratin Biomaterial 
The keratin used in this study was extracted from human hair according to modifications of a long-
established method.24  Briefly, hair from a local barber shop was washed in mild detergent and 
degreased with organic solvent.  The clean, dry, degreased hair was reduced to break cystine bonds 
that would otherwise render the keratin proteins insoluble.  After chemical reduction, a crude 
fraction of kerateines was extracted using a denaturing solution.  This solution was centrifuged, 
filtered, and dialyzed against deionized (DI) water.  The dialyzate was titrated to neutral pH, 
concentrated, and loaded into syringes.  Upon exposure to air, this so-called kerateine solution 
forms a crosslinked hydrogel.  The gel was sterilized in the syringe using gamma irradiation prior 
to use. 
 
Study outline 
The purpose of this preliminary study was to evaluate the hemostatic potential of keratin gel in a 
modestly challenging animal model.  Liver injuries are notoriously problematic as both the size 
of the liver and of the wound increase.  While the rabbit model is not proposed to be indicative of 
the human situation, it can produce both profuse and lethal hemorrhage.  We used controlled 
liver transection as a means to establish a consistent set of conditions that would result in 
exsanguination in the absence of treatment (negative control), yet provide for the recovery of test 
animals when a conventional hemostat was applied (positive control).  It should be noted that the 
hemostats used as positive controls in this study are indicated for topical wounds and require 
concomitant pressure; they were applied without compression in this study.  This was done to 
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avoid the confounding contribution compression would add as it was not used with the keratin 
gel. 
 
A total of 16 New Zealand rabbits (3.7 kg average) were used in this study.  The animals 
received a standardized liver injury that consisted of transection of approximately one third of 
the left central lobe and were then randomized into one of four groups.  Four animals served as 
negative controls and received no treatment, four animals received treatment with QuickClot, 
four animals were treated with Hemcon bandage, and four animals were treated with keratin gel.  
No resuscitation fluids were given and all animals were closely monitored during surgery.  After 
one hour the surgical wound was closed and the animals transferred to the housing facility.  All 
surviving animals were sacrificed after 72 hours.  At the time of sacrifice, liver tissue was 
retrieved for histological analysis. 
 
Surgeries and Postoperative Treatment 
All procedures were performed in accordance with Wake Forest University’s Animal Care and 
Use Committee guidelines, which encompass regulatory and accreditation agencies’ guidelines.  
The animals were weighed immediately before surgery.  All animals were sedated using a 
combination of Ketamine 10 mg/kg and Xylazine 4 mg/kg through an intramuscular injection, 
intubated and maintained on 2-3% Isoflurane for the remainder of the procedure.  The animals 
were then placed in a supine position, shaved and connected to the monitoring devices.  All 
animals were connected to ECG leads, pulse oximeter cuff on the tail, and an intra-esophageal 
probe for temperature monitoring.  After sterile prepping and draping, the abdominal incision 
was performed and the liver exposed.  Prior to the liver injury, the abdominal aorta of the 
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animals was exposed and canulated using a 23 gauge needle connected to a pressure transducer 
(Lab-stat, ADInstruments Pty. Ltd. Castle Hill, Australia) which in turn was connected to a 
PowerLab® (ADInstruments) system for data acquisition.  The mean arterial pressure (MAP) 
was recorded continuously throughout the procedure.  All animals were monitored for several 
minutes and assured to be in a stable state prior to liver injury. 
 
The median lobe of the liver was used for the injury due to its ample size and easy accessibility.  
Preliminary data during model development showed that a consistent liver injury cross sectional 
area could be created that resulted in death when left untreated, but that when treated with a 
control material could rescue the animal.  A 2.0 cm2 surface area ring was used to inflict a 
consistent sized injury to the liver by pulling the left central lobe through the ring and cutting 
immediately adjacent to the ring with a surgical blade (Figure 1).  The MAP, temperature, heart 
rate, O2 saturation, and shed blood were recorded throughout the procedure at 30 seconds, 5, 15, 
30, 45 and 60 minutes.  Shed blood was measured at each time point using pre-weighed sterile 
surgical gauze which was placed under the liver injury.  In addition, blood samples were taken 
for CBC through an ear vein. 
 
All animals were randomized into the previously mentioned four experimental groups.  The 
negative control group did not receive any treatment and the time of death was recorded in 
minutes after infliction of the injury.  As for the other experimental groups, the treatment was 
administered at the 5 minute time point unless the MAP fell to half of the starting value.  For 
standardization, the hemostatic materials applied were measured or weighed.  The keratin gel 
does not require compression so no compression was used in any of the other treatment groups 
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so as not to confound the results.  In the Hemcon treatment group, a 4.5 x 2.5 cm piece of 
bandage that was placed on the bleeding surface of the liver throughout the procedure and was 
removed prior to closure.  In the QuickClot treated group, 2.5 grams of autoclave sterilized 
material per animal was used.  The material was spread on the bleeding surface and was left after 
closure in the surviving animals.  In the case of the keratin treatment group, 2 ml of the gel was 
used per animal.  Sterile keratin gel was applied to the bleeding surface through a 1 ml syringe.  
The keratin was also left in place after closure of the animals.  These parameters were 
determined during initial model development based on complete coverage of the wound site. 
 
For the surviving animals, the monitoring continued for 60 minutes, after which the animal was 
considered to have survived the initial trauma and the bleeding stopped.  The animals that were 
treated with Hemcon had to undergo removal of the material since it could not be left intra-
abdominally as indicated by the manufacturer.  The aortic cannula was removed and hemostasis 
established at the insertion site.  No aortic bleeding was observed in any animal at necropsy.  The 
fascia and skin of the abdomen was closed. in two layers.  After complete closure of the 
abdomen, the animals were allowed to recover and transported to the housing facility where they 
were monitored every 15 minutes until complete recovery from anesthesia, then three times per 
day thereafter for the following three days.  Blood samples were taken from all surviving animals 
every day for CBC analysis.  Upon sacrifice at the 72 hour time point, the liver of each animal 
was harvested for histological evaluation.  
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Mean Arterial Pressure  
The mean arterial pressure (MAP) was recorded using a 23 gauge needle placed into the lower 
part of the abdominal aorta.  The needle was connected to a PE 50 tube which in turn was 
connected to a pressure transducer (Lab-stat) that was connected to a PowerLab system for 
pressure recording.  The MAP was continuously monitored during the entire course of the 
procedure or until the death of the animal.  To further evaluate the significance of a change in 
MAP and heart rate, shock index was used.  Shock index is a well established clinical scoring 
system for fast assessment of trauma patients.  The modified shock index was calculated by 
dividing heart rate by MAP (mmHg).  
 
Temperature 
The central temperature was recorded with an esophageal probe connected to the surgery room 
monitor.  The temperature of the animal was continuously monitored throughout the procedure 
and recorded at the previously mentioned time points. 
 
ECG and Heart Rate 
The ECG and heart rate were monitored using a three lead system connected to the surgery room 
monitor and was maintained throughout the entire procedure.  Flat line or irregular electrical 
activity with electrical mechanical dissociation was used to define the time of death. 
 
Shed blood 
Shed blood was measured by weight after subtracting the pre-weighed gauze.  Weights were 
recorded at each time point and fresh gauze placed under the liver injury.  The shed blood was 
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represented as a percent of the original body weight for each animal.  CBC was determined from 
samples taken from an ear vein on a HEMAVet® multi-species hematology system (Model 
950FS, Drew Scientific, Dallas, TX). 
 
Histology 
A tissue sample including the damaged liver surface was removed from each animal within one 
hour of euthanasia.  Each sample was placed in Tissue-Tek® O.C.T. Compound 4583 (Sakura®) 
and frozen in liquid nitrogen.  The frozen blocks were sectioned into 8μm slices using a cryostat 
(Model CM 1850, Leica Microsystems, Bannockburn, IL) to include the transected portion of the 
liver and mounted onto microscope slides.  The slides were fixed and stained with Hematoxylin 
and Eosin (H&E).  Technical difficulties in sectioning arose with both the QuikClot and the 
Hemcon sections.  The brittle QuickClot made level sectioning difficult and created voids in the 
sections.  The Hemcon bandage was removed before abdominal closure and therefore the clotted 
blood was only partially visible.  Digital images were taken (Zeiss Axio Imager M1 Microscope, 
Carl Zeiss, Thornwood, NY) at varying magnifications to observe the interactions between the 
hemostat and the damaged area of the liver.  A magnification of 100X showed the overall 
response of the tissue, while magnifications of 200X and 400X were used to visualize the 
cellular response. 
 
Statistics 
All presented data is expressed as averages and the corresponding standard deviations.  For 
statistical analysis SPSS v11 (SPSS Inc, Chicago, IL) was used.  Outliers were defined as having 
a z-score larger then +3.0 or smaller then -3.0 using a modified z-score (median of the absolute 
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deviation).  Data at all time points were analyzed by one-way analysis of variance (ANOVA).  If 
significant F values were found, the groups were further analyzed by Fischer’s Least Significant 
Difference Test (LSD).  An alpha of p<0.05 was considered significant.  The probability of a 
Type I error was minimized by limiting comparisons; only negative control versus the 3 
treatment groups were performed.  In order to compensate for bias generated by early drop out of 
dead animals (i.e. animals that exsanguinated before the end of the 60 minute operative period), 
we used polynomial regression to known pathologic endpoints to estimate values during the first 
60 minutes.  For the percent blood loss graphical data (Figure 3) where statistical relevance was 
reached with some groups, values are expressed as means with their corresponding standard error. 
 
Results 
Surgeries and Postoperative Treatment 
Negative control animals (i.e. no treatment), as expected, exsanguinated within the 60 minute 
operative period (31 ± 19 minutes).  Two animals in the QuickClot group and one in the Hemcon 
group did not survive beyond the initial 60 minute operative period.  Also in the Hemcon group, 
one animal was euthanized 24 hours post-op on the advice of the veterinary staff.  This animal 
was not ambulatory and could not eat or drink.  One animal in the keratin group was also 
sacrificed at 48 hours.  Although the animal was moving freely in its cage, it was not eating or 
drinking.  At necropsy, these animals showed no evidence of additional bleeding after the 
operative period.  All other surviving animals recovered without incident, were freely moving in 
their cages within 24 hours, and had normal CBC by 72 hours (data not shown).  A summary of 
the survival data is shown in Figure 2. 
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Shed Blood 
Blood loss was measured by weighing the surgical gauze placed below the injured liver lobe.  
The blood loss was expressed as percentage of starting body weight.  As expected in 
uncontrolled hemorrhage studies, all animals showed an initial phase of profuse bleeding 
followed by a linear phase with a lower bleeding rate, as MAP falls (Figure 3).  A comparison of 
the keratin and QuickClot groups to the negative controls shows a significantly decreased 
amount of blood loss at the 30, 45, and 60 minute time points (p values for keratin vs. negative 
control were 0.018, 0.011 and 0.007; p values for QuickClot vs. negative control were 0.009, 
0.005 and 0.004, respectively).  
 
Median Arterial Pressure  
The mean arterial pressure in the abdominal aorta was recorded for 60 minutes.  Animals in the 
keratin and Hemcon group were able to achieve stable MAPs after 5 minutes at 75% of the 
starting value.  The QuickClot and control groups failed to stabilize MAP and dropped to 45% of 
the starting value after 60 minutes (Figure 4).  However, these data did not reach statistical 
significance between groups. 
 
The shock index (SI), a predictive score grading system for the severity of blood loss, showed a 
beneficial outcome for the keratin group with low values throughout the first 60 minutes (Figure 
5).  The high values of QuickClot matched with two early deaths during the first 20 minutes of 
observation supporting the predictive nature of this measure.  Although a trend was noted, these 
data did not reach statistical significance in the present study.  
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Temperature and Heart Rate 
The liver damage model employed in this study represented severe trauma with significant, rapid 
blood loss.  None of the animals were able to compensate for loss of blood volume with an 
increase in heart rate.  All animals showed a comparable decrease from 263 bpm to 188 bpm 
after 30 minutes and 154 bpm after one hour.  There were no statistically significance differences 
between the groups.  However, the keratin group showed a trend toward compensation and 
recovery with an increase in heart rate in the second half of the surgical period from 30 min to 60 
min.  The temperature of all animals dropped in a similar fashion with a step drop of 0.8 C in the 
first 5 minutes and a total of 2.7oC over 60 minutes.  There was no statistically significant 
difference between the experimental groups. 
 
Histology 
The transected liver surfaces were examined by light microscopy of H&E stained sections.  The 
negative control group showed a clean cut with no tissue response or necrosis (Figure 6A).  
Moreover, no functional clotting was observed with little thrombus adhered to the surface.  The 
Quick Clot samples were difficult to process due to the presence of this hard, granular zeolite in 
the clot.  Histology revealed necrotic tissue mixed with blood clots (Figure 6B).  The transparent 
areas represent QuickClot particles removed during processing.  The Hemcon group showed 
some areas with clotted blood and adjacent cellular infiltration (Figure 6C).  Since the Hemcon 
bandage was removed after 60 minutes, most of the liver surfaces had only a thin layer of blood 
clots.  The keratin group showed a thick layer of biomaterial attached to the damaged liver 
surface (Figure 6D).  Granulation-like tissue with cellular infiltration had formed in the pores of 
the keratin biomaterial gel (Figure 7). 
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Discussion 
The present study was a preliminary investigation into the potential efficacy of human hair 
keratins as hemostatic hydrogels.  The liver transection produced a lethal injury, typically 
involving one or two large vessels of approximately 1mm diameter and several in the 0.5 to 1.0 
mm diameter ranges.  The severity of the injury was such that untreated rabbits all exsanguinated 
within the 60 minute operative period.  As one would expect, the survivability of the animals 
appeared to be dependent on the vascular anatomy at the injury site, which was not consistent 
from animal to animal even though the total surface area transected was controlled.  When a 
single very large bleeder (> 1 mm), or multiple large bleeders (> 2 to 3 in the 1m size range) 
were encountered within the injury area, the animal’s chance of survival was negligible in the 
QuickClot and Hemcon groups.  In the QuickClot group in particular, a single very large bleeder 
or an excess of 2 to 3 large bleeders would ensure lethality.  It should be noted however, that 
when used according to manufacturer’s instructions with concomitant pressure, other studies 
have shown better survival rates using QuickClot11 and Hemcon.25  In all cases of treatment with 
keratin gel, which was also used without any compression, the animals survived for at least 24 
hours, regardless of the size of the severed vessels.  Although a small number of animals were 
used in all test groups (n=4), these outcomes are encouraging.  
 
The keratin hemostatic gel consistently performed well by each outcome measure, particularly 
shed blood volume, MAP and importantly, survival.  One particularly distinguishing outcome 
was shock index.  In most cases of hemorrhage, cardiac output is increased to compensate for the 
drop in blood pressure.  Once this mechanism takes over, the value of shock index increases 
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rapidly and survivability becomes doubtful.  Remarkably, the shock index in the keratin 
treatment group remained the lowest of all the materials tested, consistent with early effective 
hemostasis. 
 
The keratin hemostatic gel was adherent to the tissue and hydrophilic.  When deposited onto the 
bleeding surface of the liver it was sufficiently adhesive to not be washed away, even in the 
presence of profuse bleeding.  The gel absorbed fluid from the blood and became even more 
adherent within a few minutes of administration.  Clotting and adherence was almost 
instantaneous with contact.  Interestingly, the keratin gel formed a thick seal of granulation-like 
tissue over the wound site by 72 hours.  Upon inspection of histological sections, 3 days after 
injury host cells could be seen infiltrating the gel.  We believe that the keratin gel used in these 
experiments serves two purposes.  First, contact of the gel with whole blood instigates thrombus 
formation, probably through platelet activation or concentration of clotting factors.  Second, the 
adherent gel forms a physical seal of the wound site and provides a porous scaffold for cell 
infiltration and granulation-like tissue formation, much like clotted blood. 
 
Limitations to this study include: 
 Control products not used according to manufacturer’s instructions 
 Small animal numbers 
 New model 
 No BP measurements after the first 60 minutes 
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Conclusions 
In this pilot study we demonstrated the potential efficacy of a hemostatic keratin hydrogel.  The 
gel was derived from keratins extracted from human hair, a plentiful and renewable resource.  
The process for producing the gels is relatively simple, non-inflammatory, absorbable, scalable, 
and efficient.  The present study demonstrated initial efficacy in arresting hemorrhage and most 
importantly improving survivability in a rabbit model of liver injury, Future studies will address 
arterial or liver bleeding in larger models, including those with a coagulopathy.  
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Figure Legends 
 
Figure 1.  Application of Keratin Gel:  A) the ring device is placed around the left central lobe 
of the liver.  B) 5 minutes after generation of the standard liver trauma or drop to 50% of starting 
MAP the keratin gel was applied.  C) Image taken 2 minutes after applying the keratin gel, 
showing some remnant bleeding.  D) Image taken after 20 minutes showing hemostasis. 
 
Figure 2.  Kaplan-Mayer survival graph:  Time is presented in minutes on a logarithmic scale. 
All animals in the control group died within 60 minutes.  One animal form the keratin and one 
from the Hemcon group was sacrificed upon recommendation of the animal care staff.  Overall, 
keratin outperformed the other groups with only one death compared with 2 deaths in the 
QuickClot and Hemcon groups. 
 
Figure 3.  Shed blood:  Blood loss is normalized to body weight and expressed at percentage of 
body weight.  Keratin and QuickClot group lost significantly (*) less blood than the control and 
Hemcon group.  
 
Figure 4.  Mean Arterial Pressure (MAP):  Blood pressure is expressed in percentage of initial 
pressure.  The negative control and Quick clot group showed a steep drop in pressure to 40% of 
initial map.  Animals treated with keratin or Hemcon were able to stabilize the map around 80% 
of initial pressure.  These differences were not statistically different compared to the control 
group.  
 
 22
Hemostatic keratin biomaterial 
Figure 5.  Shock Index (SI):  The modified shock index was calculated by dividing heart rate by 
MAP.  This index is clinically used to asses the severity of a shock with low values being better.  
The animals in the keratin groups showed compensated low values over the entire study period 
while QuickClot and Hemcon had similar values as the negative control.  There was no statistical 
significance between the groups. 
 
Figure 6.  Histological Assessment:  Representative tissue sections stained with hematoxylin 
and eosin, 50x.  A) The negative control group shows signs of poor perfusion with wide and 
empty sinusoids.  The surface is lacking a functional blood clot.  B) The surface of the QuickClot 
treated samples show area of necrosis (arrow) and clotting.  Only minimal cellular infiltration 
and tissue regeneration is visible.  The void areas represent the removed QuickClot granules.  C) 
Tissue samples from Hemcon treated animals showed patchy areas of adherent clotted blood 
where there was a low level of cellular infiltration.  D) Liver samples from animals treated with 
keratin show a thick layer of keratin biomaterial attached to the injured surface.  There are signs 
of excellent biocompatibility with a high cellular activity and the formation of early granular 
tissue (large arrow) in the spaces between the keratin.  Further, there is a high level of direct 
contact of hepatocytes with the keratin biomaterial (small arrow). 
 
Figure 7:  Keratin treated group, high magnification:  A) Formation of early granulation-like 
tissue within the spaces of the keratin gel, 200x.  B) Interface between keratin gel and liver tissue 
showing integration of the biomaterial and tissue, and early cellular infiltration, 400x. 
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